Amicus Therapeutics (FOLD) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

FOLD is expected to report earnings to fall 50.80% to -2 cents per share on November 05

Amicus Therapeutics FOLD Stock Earnings Reports

Q3'24

Est.

$-0.02

Q2'24

Est.

$-0.05

Q1'24

Beat

by $0.04

Q4'23

Beat

by $0.07

Q3'23

Beat

by $0.01

The last earnings report on August 08 showed earnings per share of -5 cents, beating the estimate of -5 cents. With 1.75M shares outstanding, the current market capitalization sits at 3.18B.

View a ticker or compare two or three

Compare

FOLD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For FOLD
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for FOLD (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

47 Hulfish Street

Phone

+1 609 662-2000

Employees

517

Web

https://www.amicusrx.com